FIGURE

Fig. 4

ID
ZDB-FIG-240508-40
Publication
Zhao et al., 2023 - Multiple gene-drug prediction tool reveals Rosiglitazone based treatment pathway for non-segmental vitiligo
Other Figures
All Figure Page
Back to All Figure Page
Fig. 4

Effect of PPAR-γ signaling pathway on melanogenesis. aL-dopa staining of melanoma cells (Mum-2C) treated with rosiglitazone and GW9662 for 48 h. b Quantification of melanogenesis by L-dopa staining. c Immunofluorescence of TYR in melanoma cells for 48 h. d Immunofluorescence of PPAR-γ in melanoma cells for 48 h. Data represent mean ± 95% confidence interval (CI) ***p < 0.001; ****p < 0.0001; n = 7.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Inflammation